Debate Rages Over Safety Of CRISPR Gene-Editing Technique – IFLScience
IFLScience |
Debate Rages Over Safety Of CRISPR Gene-Editing Technique
IFLScience In the last few years, CRISPR – the precise and easily available gene-editing technique – has gone from strength to strength. Right now, it’s more potential than practical, but its uses are almost countless. From removing genetic diseases from babies … |
|
Capricor yo-yos as J&J dumps stem cell partnership
FierceBiotech After three and a half years, Johnson & Johnson is ducking out of a partnership with Capricor Therapeutics focused on the use of stem cells to treat cardiovascular disease. The decision by J&J’s Janssen unit not to pursue a license comes as little … |
Hindustan Times |
Diabetes alert: Stem Cell Educator therapy is safe and effective for treatment
Hindustan Times New research has revealed that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes. The therapy is believed to provide benefits because abnormalities in multiple types of immune cells contribute … Brothers Michael and Alex Wood share a stem cell bond at the Stadium StompThe Advertiser The Global Market for Induced Pluripotent Stem Cells (iPSCs) should reach $3.6 Billion in 2021, Increasing at a CAGR …Business Wire (press release) ‘Educated’ immune cells hold promise for fight against diabeteseHealth Magazine | Elets |
|
Colon Cancer-Driven Stem Cells Linked to High-Fat Diet
Genetic Engineering & Biotechnology News Their research is published today, in Stem Cell Reports, in a paper titled, “RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.” The Cleveland Clinic team’s review of published research … |
Washington Post |
Scientists synthesize smallpox cousin in ominous breakthrough
Washington Post “It’s not one of the leading universities in the world for microbiology and synthetic biology. If it came out of there, how many other places like this are also doing the same work right now?” He said the U.S. government is unprepared to handle an … |
Newsmax |
Sophie’s Choice for Oncologists: Who Gets New Life-Saving Drug
Newsmax Unlike pills or chemotherapy, the therapy known as CAR–T can’t be stockpiled. Because it’s a bespoke treatment that involves re-engineering a patient’s cells in a specialized lab, the logistics of getting CAR–T to the thousands of Americans who will be … Novartis AG (ADR) (NYSE:NVS) To Face FDA Panel For Cancer Treatment, Kite Pharma Inc (NASDAQ:KITE) Could …Market Exclusive |